THERAPEUTIC EXPERIENCECirculatory: Deep vein thrombosis and pulmonary embolismEndocrinology: Diabetes type 2Pulmonology: Asthma in children 6-11 years oldOncology: Colorectal cancer, Gastrointestinal Cancer (two trials), Breast Cancer (two trials)Osteology: Corticoid-induced OsteoporosisGastroenterology: Intra-abdominal infections treatment with antibioticsNeurology: Multiple SclerosisCOMPUTER EXPERIENCEWindows, MS Word, MS Excel, MS Outlook, PowerPoint, Adobe Acrobat, Oracle Inform EDC, Rave EDC, IVRS. CLINICAL TRIAL EXPERIENCE: 8+ clinical trialsPublications:Shuba Y.M., Degtiar V.E., Osipenko V.N., Naidenov V.G., Woosley R.L."Testosterone-mediated modulation of HERG blockade by proarrhythmic agents."Biochem Pharmacol. 2001 Jul 1;62(1):41-9. Osypenko V.M., Dehtiar V.Ie., Shuba Ia.M., Naĭd’onov V.H.."Testosterone modulation of HERG potassium channel blockade induced by neuroleptics."Fiziol Zh. 2001;47(3):11-8. Osypenko V.M., Dehtiar V.Ie., Naidionov V.H., Shuba Ia.M."Effects of sex hormones on HERG potassium channels expressed in Xenopus oocytes."Fiziol Zh. 2001;47(2):24-31. Osypenko V.M., Degtiar V.Ie., Naid’onov V.G., Shuba Ia.M."Blockade of HERG K+ channels expressed in Xenopus oocytes by antipsychotic agents." Fiziol Zh. 2001;47(1):17-25. Shcheglovitov A., Zhelay T., Vitko Y., Osipenko V., Perez-Reyes E, Kostyuk P, Shuba Y. "Contrasting the effects of nifedipine on subtypes of endogenous and recombinant T-type Ca2+ channels." Biochem. Pharmacol. 2005 Mar 1;69(5):841-54. Epub 2005 Jan 12.